Table 2.

Comparison of Unadjusted and Adjusted Beta Coefficients for Public FQHC Compared to Private FQHC on Eleven Quality Outcomes

Outcome measure	Mean (private FQHC)	Unadjusted B (SE) public FQHC*	p value	Adjusted B (SE) public FQHC**	p value
BP control (<140/90)	0.64	−.03(.01)	.004	−.03(.01)	.030
Cervical cancer screening	0.52	−.03(.02)	.10	−.03(.02)	.050
Colorectal cancer screening	0.43	−.05(.02)	.003	−.03(.02)	.053
Statin therapy	0.7	−.02(.01)	.057	−.03(.01)	.058
Asthma treatment	0.95	−.02(.01)	.14	.02(.01)	.13
Access to prenatal screening	0.78	−.04(.02)	.03	−.02(.01)	.20
Uncontrolled DM (A1c > 9)	0.32	.01(.01)	.40	−.01(.01)	.62
Depression screening	0.71	.00(.02)	.99	−.01(.02)	.67
Adults receiving tobacco cessation	0.85	−.002(.01)	.88	−.01(.01)	.69
Childhood immunization	0.35	.01(.02)	.57	.003(.02)	.91

*Univariate linear regression

**Multivariate linear regression with controls for proportion of patients uninsured, age over 65, income below poverty level, and rural location as defined by USDA Rural-Urban Continuum Code > 3